Response to Letter by Gibson
- Edzard Ernst, MD, PHD, FRCP (EDIN)
- From the Department of Complementary Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, Exeter, U.K
I am obliged to Nathaniel Gibson (1) for his letter in this issue of Diabetes Care because his comments enable me to clarify several points. He is correct in calling part of the evidence I quoted “anecdotal.” This pertains particularly to the cases where providers of complementary and alternative medicine (CAM) have hindered access to essential conventional treatments. Sadly, at the current time, such information can only …
